Related Experiment Video
Updated: Jul 15, 2026
07:50
Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
Published on: September 18, 2020
MGMT hypermethylation: a prognostic foe, a predictive friend
Filipe V Jacinto1, Manel Esteller
1Cancer Epigenetics Laboratory, Molecular Pathology Programme, Spanish National Cancer Centre (CNIO), Madrid, Spain.
DNA Repair
|May 8, 2007
Summary
DNA repair gene silencing via O(6)-methylguanine-DNA methyltransferase (MGMT) promoter hypermethylation drives cancer mutations and increases tumor sensitivity to alkylating drugs, highlighting its importance in cancer research.
Area of Science:
- Molecular Biology
- Cancer Genetics
- Epigenetics
Background:
- DNA alkylation at the O(6)-guanine position is a critical event in mutagenesis, carcinogenesis, and cell death.
- O(6)-alkylguanine-DNA alkyltransferase (AGT), also known as O(6)-methylguanine-DNA methyltransferase (MGMT), repairs these DNA adducts.
- Epigenetic silencing of MGMT through promoter CpG island hypermethylation is observed in various human tumors.
Purpose of the Study:
- To investigate the consequences of MGMT epigenetic inactivation in human cancer.
- To explore the role of MGMT promoter hypermethylation in cancer development and treatment response.
Main Methods:
- Analysis of MGMT gene expression and promoter methylation status in tumor samples.
- Correlation studies between MGMT methylation and mutation accumulation.
- Assessment of the relationship between MGMT methylation and sensitivity to alkylating chemotherapeutic agents.
Main Results:
- Epigenetic inactivation of MGMT leads to a mutator phenotype, promoting G-to-A transition mutations.
- MGMT promoter hypermethylation is significantly correlated with increased tumor sensitivity to alkylating drugs.
- These findings underscore the critical role of MGMT in genomic stability and therapeutic outcomes.
Conclusions:
- MGMT promoter hypermethylation is a key event in a subset of human cancers, contributing to genomic instability.
- The epigenetic status of MGMT is a predictive biomarker for response to alkylating chemotherapy.
- Understanding MGMT epigenetic regulation is crucial for both basic cancer research and clinical applications.
Related Concept Videos
01:37Epigenetic Regulation
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
01:46Epigenetic Regulation
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
01:17Phase II Reactions: Methylation Reactions
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...